Literature DB >> 25563363

Cathepsin S as a cancer target.

L Zhang, H Wang, J Xu.   

Abstract

UNLABELLED: Cathepsin S is a lysosomal enzyme that belongs to the papain family of cysteine proteases. Multiple studies indicate that cathepsin S acts not only as a crucial role in antigen presentation but also as an important protagonist of cancers. Cathepsin S has been shown to participate in dissolution and remodelling of connective tissue and basement membranes, resulting in the process of tumor growth, invasion, metastasis and angiogenesis. Therefore, cathepsin S has been suggested as a potential therapeutic target in cancer therapy. In the present study, we review the rapidly advancing field of cathepsin S in cancer therapy, highlighting the specific roles of cathepsin S in cancer. KEYWORDS: Cathepsin S, cancer, combined chemotherapy, inhibitors.

Entities:  

Year:  2015        PMID: 25563363     DOI: 10.4149/neo_2015_003

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  10 in total

Review 1.  Engineered nanomaterial-induced lysosomal membrane permeabilization and anti-cathepsin agents.

Authors:  Melisa Bunderson-Schelvan; Andrij Holian; Raymond F Hamilton
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017       Impact factor: 6.393

2.  Mucopolysaccharidosis Type IVA: Extracellular Matrix Biomarkers in Cardiovascular Disease.

Authors:  Brittany Montavon; Linda E Winter; Qi Gan; Amirhossein Arasteh; Adriana M Montaño
Journal:  Front Cardiovasc Med       Date:  2022-05-10

3.  Systemic inflammation and protease profile of Afro-Caribbean patients with sepsis.

Authors:  Panid Borhanjoo; Navneet Singh; Sridesh Nath; Md Sadakat Chowdhury; Carl Swanson; Ryan Kaiser; Patrick Geraghty; Robert F Foronjy; Lillian Chow
Journal:  SAGE Open Med       Date:  2021-04-28

4.  Inhibition of cathepsin S confers sensitivity to methyl protodioscin in oral cancer cells via activation of p38 MAPK/JNK signaling pathways.

Authors:  Ming-Ju Hsieh; Chiao-Wen Lin; Mu-Kuan Chen; Su-Yu Chien; Yu-Sheng Lo; Yi-Ching Chuang; Yi-Ting Hsi; Chia-Chieh Lin; Jui-Chieh Chen; Shun-Fa Yang
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

5.  Sulforaphane suppresses oral cancer cell migration by regulating cathepsin S expression.

Authors:  Chang-Tai Chen; Ming-Ju Hsieh; Yi-Hsien Hsieh; Min-Chieh Hsin; Yi-Ting Chuang; Shun-Fa Yang; Jia-Sin Yang; Chiao-Wen Lin
Journal:  Oncotarget       Date:  2018-04-03

Review 6.  Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy.

Authors:  Valeria De Pasquale; Anna Moles; Luigi Michele Pavone
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

7.  Cysteine Cathepsins Inhibition Affects Their Expression and Human Renal Cancer Cell Phenotype.

Authors:  Magdalena Rudzińska; Alessandro Parodi; Valentina D Maslova; Yuri M Efremov; Neonila V Gorokhovets; Vladimir A Makarov; Vasily A Popkov; Andrey V Golovin; Evgeni Y Zernii; Andrey A Zamyatnin
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

Review 8.  Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment.

Authors:  Anamarija Habič; Metka Novak; Bernarda Majc; Tamara Lah Turnšek; Barbara Breznik
Journal:  J Histochem Cytochem       Date:  2021-07-26       Impact factor: 2.479

Review 9.  Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics.

Authors:  Ryan Brown; Sridesh Nath; Alnardo Lora; Ghassan Samaha; Ziyad Elgamal; Ryan Kaiser; Clifford Taggart; Sinéad Weldon; Patrick Geraghty
Journal:  Respir Res       Date:  2020-05-12

Review 10.  Lysosomal peptidases-intriguing roles in cancer progression and neurodegeneration.

Authors:  Janko Kos; Ana Mitrović; Milica Perišić Nanut; Anja Pišlar
Journal:  FEBS Open Bio       Date:  2022-02-03       Impact factor: 2.693

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.